|
|
| Line 1: |
Line 1: |
| [[Image:2jpz.gif|left|200px]] | | {{Seed}} |
| | [[Image:2jpz.png|left|200px]] |
|
| |
|
| <!-- | | <!-- |
| Line 9: |
Line 10: |
| {{STRUCTURE_2jpz| PDB=2jpz | SCENE= }} | | {{STRUCTURE_2jpz| PDB=2jpz | SCENE= }} |
|
| |
|
| '''Structure of the hybrid-2 type intramolecular human telomeric G-quadruplex'''
| | ===Structure of the hybrid-2 type intramolecular human telomeric G-quadruplex=== |
|
| |
|
|
| |
|
| ==Overview==
| | <!-- |
| Formation of the G-quadruplex in the human telomeric sequence can inhibit the activity of telomerase, thus the intramolecular telomeric G-quadruplexes have been considered as an attractive anticancer target. Information of intramolecular telomeric G-quadruplex structures formed under physiological conditions is important for structure-based drug design. Here, we report the first structure of the major intramolecular G-quadruplex formed in a native, non-modified human telomeric sequence in K(+) solution. This is a hybrid-type mixed parallel/antiparallel-G-stranded G-quadruplex, one end of which is covered by a novel T:A:T triple capping structure. This structure (Hybrid-2) and the previously reported Hybrid-1 structure differ in their loop arrangements, strand orientations and capping structures. The distinct capping structures appear to be crucial for the favored formation of the specific hybrid-type intramolecular telomeric G-quadruplexes, and may provide specific binding sites for drug targeting. Our study also shows that while the hybrid-type G-quadruplexes appear to be the major conformations in K(+) solution, human telomeric sequences are always in equilibrium between Hybrid-1 and Hybrid-2 structures, which is largely determined by the 3'-flanking sequence. Furthermore, both hybrid-type G-quadruplexes suggest a straightforward means for multimer formation with effective packing in the human telomeric sequence and provide important implications for drug targeting of G-quadruplexes in human telomeres.
| | The line below this paragraph, {{ABSTRACT_PUBMED_17626043}}, adds the Publication Abstract to the page |
| | (as it appears on PubMed at http://www.pubmed.gov), where 17626043 is the PubMed ID number. |
| | --> |
| | {{ABSTRACT_PUBMED_17626043}} |
|
| |
|
| ==About this Structure== | | ==About this Structure== |
| Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2JPZ OCA]. | | Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2JPZ OCA]. |
|
| |
|
| ==Reference== | | ==Reference== |
| Line 29: |
Line 33: |
| [[Category: Nmr]] | | [[Category: Nmr]] |
| [[Category: Quadruplex]] | | [[Category: Quadruplex]] |
| ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 09:10:15 2008'' | | |
| | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 00:15:42 2008'' |